Yang Yoonsun, Swennenhuis Joost F, Rho Hoon Suk, Le Gac Séverine, Terstappen Leon W M M
Medical Cell BioPhysics Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
Mesoscale Chemical Systems Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
PLoS One. 2014 Sep 18;9(9):e107958. doi: 10.1371/journal.pone.0107958. eCollection 2014.
The heterogeneity of tumor cells and their alteration during the course of the disease urges the need for real time characterization of individual tumor cells to improve the assessment of treatment options. New generations of therapies are frequently associated with specific genetic alterations driving the need to determine the genetic makeup of tumor cells. Here, we present a microfluidic device for parallel single cell whole genome amplification (pscWGA) to obtain enough copies of a single cell genome to probe for the presence of treatment targets and the frequency of its occurrence among the tumor cells. Individual cells were first captured and loaded into eight parallel amplification units. Next, cells were lysed on a chip and their DNA amplified through successive introduction of dedicated reagents while mixing actively with the help of integrated button-valves. The reaction chamber volume for scWGA 23.85 nl, and starting from 6-7 pg DNA contained in a single cell, around 8 ng of DNA was obtained after WGA, representing over 1000-fold amplification. The amplified products from individual breast cancer cells were collected from the device to either directly investigate the amplification of specific genes by qPCR or for re-amplification of the DNA to obtain sufficient material for whole genome sequencing. Our pscWGA device provides sufficient DNA from individual cells for their genetic characterization, and will undoubtedly allow for automated sample preparation for single cancer cell genomic characterization.
肿瘤细胞的异质性及其在疾病过程中的变化促使需要对单个肿瘤细胞进行实时表征,以改进对治疗方案的评估。新一代疗法通常与特定的基因改变相关,这推动了确定肿瘤细胞基因组成的需求。在此,我们展示了一种用于平行单细胞全基因组扩增(pscWGA)的微流控装置,以获得单个细胞基因组的足够拷贝数,从而探测治疗靶点的存在及其在肿瘤细胞中的出现频率。首先将单个细胞捕获并加载到八个平行的扩增单元中。接下来,细胞在芯片上裂解,其DNA通过依次引入专用试剂并在集成纽扣阀的帮助下积极混合来进行扩增。scWGA的反应室体积为23.85 nl,从单个细胞中包含的6 - 7 pg DNA开始,WGA后获得了约8 ng DNA,代表超过1000倍的扩增。从该装置收集单个乳腺癌细胞的扩增产物,以直接通过qPCR研究特定基因的扩增,或对DNA进行再扩增以获得足够的材料用于全基因组测序。我们的pscWGA装置为单个细胞提供了足够的DNA用于其基因表征,无疑将允许为单个癌细胞基因组表征进行自动化样品制备。